Integrated Program in Neuroscience - Block 3

Blood proteins flag multiple sclerosis years before diagnosis, opening a window for prevention

ɬ�﷬ — Tue, 26 May 2026 14:12:51 +0000

Of more than 2,500 blood proteins screened, a small group may drive MS and signal who will develop it

A new study has revealed a group of blood proteins, that are altered in people who go on to develop multiple sclerosis (MS), in some cases more than a decade before diagnosis. The findings offer hope that a simple blood test could one day identify people at high risk of MS in time to act before damage occurs.

Neuro researchers lead projects awarded $14.5 million

ɬ�﷬ — Wed, 18 Mar 2026 13:31:29 +0000

Funds will help acquire and develop cutting-edge infrastructure to advance research capacity

Five researchers from The Neuro (Montreal Neurological Institute-Hospital) are leading innovative new projects that have received major funding from Canada Foundation for Innovation’s Innovation Fund. They will be funded for a total of $14.5 million, part of $42 million going to ɬ�﷬ scientists.

Leading through change: Three Canadian university leaders reflect on implications of gen AI for higher ed

ɬ�﷬ — Wed, 11 Mar 2026 19:22:18 +0000

We recently had the opportunity to ask senior leaders from three of Canada’s top universities a big question: “How is generative AI reshaping higher education?”

Findings of ɬ�﷬ study could lead to new longevity therapies and improved fall prevention

ɬ�﷬ — Mon, 23 Feb 2026 14:46:40 +0000

A new ɬ�﷬ study has found a direct link between age‑related declines in neuron activity in the cerebellum and worsening motor skills, including gait, balance and agility. While it is well known that these abilities diminish with age, this is the first research to pinpoint how changes in Purkinje cells – a key type of cerebellar neuron – drive this decline and translate into measurable changes in behaviour and physical function.

RNA therapy may be a solution for infant hydrocephalus

ɬ�﷬ — Thu, 29 Jan 2026 16:57:57 +0000

For the first time, drug targeting genetic mutation shown to have positive impact in mice models

Hydrocephalus is a life-threatening condition that occurs in about 1 in 1,000 newborns and is often treated with invasive surgery. Now, a new study offers hope of preventing hydrocephalus before it even occurs.